At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 24 enrolled
Drug / intervention
Dexamethasone +1 moredrug
Likely dose
Dexamethasone 0.1 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Postoperative Dexamethasone on Post-Cesarean Pain in Patients Using Medication Assisted Treatment (MAT)
In Brief
A Phase 4 clinical trial evaluating Dexamethasone and placebo for Post-Cesarean Pain and Cesarean Section Complications. Completed, enrolled 24 participants across 1 site.
Detailed Summary
Investigating if giving post-operative dexamethasone to patients with a history of opioid use disorder on medication assisted treatment during pregnancy improves their pain scores and decreases their opioid use after cesarean section.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost-Cesarean Pain, Cesarean Section Complications
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2020202120222023202420252026
First PostedAug 2019
Enrollment StartJul 2020
Primary CompletionApr 2024
TodayJul 2026
First PostedAug 26, 2019
Enrollment StartJul 20, 2020
Primary CompletionApr 1, 2024
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 6.9 years ago
Interventions
Dexamethasonedrug
subjects will receive a single administration of either 0.1 mg/kg of intravenous dexamethasone in 90mL of normal saline
placeboother
100mL of normal saline (placebo)